Vainio, L.; Taponen, S.; Kinnunen, S.M.; Halmetoja, E.; Szabo, Z.; Alakoski, T.; Ulvila, J.; Junttila, J.; Lakkisto, P.; Magga, J.;
et al. GSK3β Serine 389 Phosphorylation Modulates Cardiomyocyte Hypertrophy and Ischemic Injury. Int. J. Mol. Sci. 2021, 22, 13586.
https://doi.org/10.3390/ijms222413586
AMA Style
Vainio L, Taponen S, Kinnunen SM, Halmetoja E, Szabo Z, Alakoski T, Ulvila J, Junttila J, Lakkisto P, Magga J,
et al. GSK3β Serine 389 Phosphorylation Modulates Cardiomyocyte Hypertrophy and Ischemic Injury. International Journal of Molecular Sciences. 2021; 22(24):13586.
https://doi.org/10.3390/ijms222413586
Chicago/Turabian Style
Vainio, Laura, Saija Taponen, Sini M. Kinnunen, Eveliina Halmetoja, Zoltan Szabo, Tarja Alakoski, Johanna Ulvila, Juhani Junttila, Päivi Lakkisto, Johanna Magga,
and et al. 2021. "GSK3β Serine 389 Phosphorylation Modulates Cardiomyocyte Hypertrophy and Ischemic Injury" International Journal of Molecular Sciences 22, no. 24: 13586.
https://doi.org/10.3390/ijms222413586
APA Style
Vainio, L., Taponen, S., Kinnunen, S. M., Halmetoja, E., Szabo, Z., Alakoski, T., Ulvila, J., Junttila, J., Lakkisto, P., Magga, J., & Kerkelä, R.
(2021). GSK3β Serine 389 Phosphorylation Modulates Cardiomyocyte Hypertrophy and Ischemic Injury. International Journal of Molecular Sciences, 22(24), 13586.
https://doi.org/10.3390/ijms222413586